<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8809320</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1600</journal-id>
<journal-id journal-id-type="nlm-ta">Neuron</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuron</journal-id>
<journal-title-group>
<journal-title>Neuron</journal-title>
</journal-title-group>
<issn pub-type="ppub">0896-6273</issn>
<issn pub-type="epub">1097-4199</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30679017</article-id>
<article-id pub-id-type="pmc">6733271</article-id>
<article-id pub-id-type="doi">10.1016/j.neuron.2018.12.026</article-id>
<article-id pub-id-type="manuscript">NIHMS1048806</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Increased excitation-inhibition ratio stabilizes synapse and circuit excitability in four autism mouse models</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Antoine</surname>
<given-names>Michelle W.</given-names>
</name>
<xref ref-type="author-notes" rid="FN3">*</xref>
<xref ref-type="corresp" rid="CR1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Langberg</surname>
<given-names>Tomer</given-names>
</name>
<xref ref-type="author-notes" rid="FN3">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Schnepel</surname>
<given-names>Philipp</given-names>
</name>
<xref ref-type="author-notes" rid="FN5">2</xref>
<xref ref-type="author-notes" rid="FN3">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Feldman</surname>
<given-names>Daniel E.</given-names>
</name>
<xref ref-type="corresp" rid="CR1">†</xref>
<xref ref-type="author-notes" rid="FN4">1</xref>
</contrib>
<aff id="A1">Dept. of Molecular and Cellular Biology and Helen Wills Neuroscience Institute, UC Berkeley, Berkeley, CA 94720</aff>
</contrib-group>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">Author Contributions</p>
<p id="P2">MA, TL, PS: Designed, performed and analyzed in vitro (MA) and in vivo (TL, PS) experiments. DF: Designed experiments and performed modeling. MA, TL, DF: Co-wrote paper.</p>
</fn>
<fn fn-type="equal" id="FN3">
<label>*</label>
<p id="P3">Equal authorship</p>
</fn>
<fn fn-type="other" id="FN4">
<label>1</label>
<p id="P4">Lead contact</p>
</fn>
<fn fn-type="present-address" id="FN5">
<label>2</label>
<p id="P5">Current address: Max Delbrück Center for Molecular Medicine, Berlin, Germany</p>
</fn>
<corresp id="CR1"><label>†</label>Co-corresponding authors. Correspondence should be addressed to: 142 Life Sciences Addition, # 3200, MCB Dept., University of California, Berkeley, Berkeley, CA 92093-3200, <email>mwantoine@berkeley.edu</email>, <email>dfeldman@berkeley.edu</email></corresp>
<fn fn-type="COI-statement" id="FN6">
<p id="P102">Declaration of Interests</p>
<p id="P103">The authors declare no competing interests.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>4</day>
<month>9</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>21</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="ppub">
<day>20</day>
<month>2</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>20</day>
<month>2</month>
<year>2020</year>
</pub-date>
<volume>101</volume>
<issue>4</issue>
<fpage>648</fpage>
<lpage>661.e4</lpage>
<!--elocation-id from pubmed: 10.1016/j.neuron.2018.12.026-->
<abstract id="ABS1">
<title>Summary</title>
<p id="P6">Distinct genetic forms of autism are hypothesized to share a common increase in excitation-inhibition (E-I) ratio in cerebral cortex, causing hyperexcitability and excess spiking. We provide a systematic test of this hypothesis across 4 mouse models (<italic>Fmr1</italic><sup>−/<italic>y</italic></sup>, <italic>Cntnap2</italic><sup>−/−</sup>, <italic>16p11.2</italic><sup><italic>del</italic>/+</sup>, <italic>Tsc2</italic><sup>+/−</sup>), focusing on somatosensory cortex. All autism mutants showed reduced feedforward inhibition in layer 2/3 coupled with more modest, variable reduction in feedforward excitation, driving a common increase in E-I conductance ratio. Despite this, feedforward spiking, synaptic depolarization and spontaneous spiking were largely normal. Modeling revealed that E and I conductance changes in each mutant were quantitatively matched to yield stable, not increased, synaptic depolarization for cells near spike threshold. Correspondingly, whisker-evoked spiking was not increased <italic>in vivo</italic>, despite detectably reduced inhibition. Thus, elevated E-I ratio is a common circuit phenotype, but appears to reflect homeostatic stabilization of synaptic drive, rather than driving network hyperexcitability in autism.</p>
</abstract>
<kwd-group>
<kwd>E-I ratio</kwd>
<kwd>cerebral cortex</kwd>
<kwd>somatosensory cortex</kwd>
<kwd>circuit excitability</kwd>
<kwd>Fragile X</kwd>
<kwd>homeostasis</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>